Antibiotic pharmacokinetics in infected pleural effusions

Area of Science:

• Pharmacokinetics
• Infectious Diseases
• Thoracic Medicine

Background:

• Pleural infection treatment typically relies on empirical broad-spectrum antibiotics.
• Limited data exist regarding antibiotic penetration into the infected pleural space.
• Understanding drug concentrations in pleural fluid is crucial for effective treatment.

Purpose of the Study:

• To evaluate the pharmacokinetic penetration of commonly used intravenous antibiotics into infected pleural fluid.
• To determine if antibiotic concentrations in pleural fluid achieve therapeutic levels.
• To address existing concerns about antibiotic efficacy in pleural infections.

Main Methods:

• A pharmacokinetic study was conducted involving 35 patients with pleural infection.
• Antibiotic concentrations of amoxicillin, metronidazole, piperacillin-tazobactam, clindamycin, and cotrimoxazole were measured.
• Concentrations were analyzed at 146 time points in pleural fluid and blood.

Main Results:

• Amoxicillin, metronidazole, piperacillin-tazobactam, and clindamycin achieved pleural fluid concentrations comparable to blood levels.
• These concentrations were well above the minimum inhibitory concentrations (MICs) for relevant pathogens.
• Cotrimoxazole showed lower penetration compared to other tested antibiotics.

Conclusions:

• Commonly prescribed antibiotics (excluding cotrimoxazole) demonstrate adequate penetration into the infected pleural space.
• Therapeutic antibiotic levels in pleural fluid support their use in treating pleural infections.
• The study refutes widespread concerns regarding poor antibiotic penetration in pleural infections.